Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationale

Abstract Background COVID-19 associated acute respiratory distress syndrome (CARDS) is a severe form of SARS CoV-2 infection and affects about 15–30% of hospitalized patients with a high mortality rate. Growing research and data suggest several available drugs with appropriate pharmacological effect...

Full description

Bibliographic Details
Main Authors: Eka Prasetya Budi Mulia, Kevin Luke
Format: Article
Language:English
Published: SpringerOpen 2021-09-01
Series:The Egyptian Heart Journal
Subjects:
Online Access:https://doi.org/10.1186/s43044-021-00208-y